3.2600
-0.0200
(-0.61%)
As of 1:08:23 PM GMT+1. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Harald Nordal M.B.A., M.Sc., MBA, MSc | Co-Founder & Chairman | -- | -- | 1958 |
| Mr. Christer L. Valderhaug | Chief Executive Officer | -- | -- | 1972 |
| Mr. Hogne Hallaraker | Founder & Chief Scientific Officer | -- | -- | 1966 |
| Mr. Jone R. Slinning | Chief Financial Officer | -- | -- | 1979 |
| Mr. Per Christian Sæbo | Chief Operating Officer | -- | -- | 1967 |
| Mr. Daniele Mancinelli | Chief Technical Officer | -- | -- | 1973 |
| Mr. Steffen Erland Eidal | Senior Vice President of Sales & Marketing | -- | -- | 1966 |
| Dr. Yuming Feng | Executive Vice President of Global Business Development | -- | -- | 1963 |
| Dr. Runhild Gammelsæter | Global Medical Director | -- | -- | 1976 |
Arctic Bioscience AS
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand worldwide. The company was incorporated in 2011 and is headquartered in Ørsta, Norway.
Corporate Governance
Arctic Bioscience AS’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ELIC.ST Elicera Therapeutics AB (publ)
3.3600
+1.20%
NXTCL.ST NextCell Pharma AB
2.8600
-0.69%
ACE.ST Ascelia Pharma AB (publ)
2.8750
+0.52%
GANX Gain Therapeutics, Inc.
2.2000
+5.26%
ALZN Alzamend Neuro, Inc.
1.1500
+2.68%
APRE Aprea Therapeutics, Inc.
3.8000
+2.43%
ADPT Adaptive Biotechnologies Corporation
7.86
+1.95%
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
UBX Unity Biotechnology, Inc.
2.1400
-4.46%
ELEV Elevation Oncology, Inc.
0.6666
+7.78%